Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06186128 · ClinicalTrials.gov registry record · NA

Universal Basic Income and Structural Racism in the US South: HIV Care

A NA study of HIV and Health Care Utilization, sponsored by University of Arkansas.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06186128: Recruiting NA study of HIV and Health Care Utilization, sponsored by University of Arkansas.

NCT06186128 is a NA study of HIV and Health Care Utilization that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06186128, a NA study of HIV and Health Care Utilization, is actively recruiting participants, sponsored by University of Arkansas.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Universal Basic Income (UBI) is a promising strategy aimed at recalibrating economic systems that are grounded in structural racism. Black men have long been the target of oppressive and interconnected systems of finance and healthcare access, leading to a disproportionate burden of exposure to infectious disease with little healthcare support. Yet to our knowledge, no published UBI studies have ever been implemented exclusively with Black men living with HIV in the US. Motivated and inspired by the innovative health and social science being conducted in extremely resource-limited environments in other parts of the world, we recognize an urgent need to better understand the effect of cash transfers on HIV care among Black men in the US South. The proposed study will be based in Arkansas, which, like other Southern states, has a long history of institutional racism and extremely high rates of racial health disparities, poverty, and chronic disease. We will use a mixed methods research design to conduct an in-depth exploration of a UBI intervention to reduce the racial wage gap and promote the use of culturally relevant protective factors. The provision of a UBI is intended to increase receipt and retention of HIV care services and treatment for Black men through the influx of capital and subsequent increases in culturally-based protective factors such as personal agency and social connections. We hypothesize that providing UBI of $500 per month for 6 months will result in increased HIV care utilization among low-income Black men living with HIV. Secondarily, we hypothesize that the effect of UBI will also increase adherence to HIV medication, such that more UBI recipients will achieve and maintain viral suppression compared to individuals in the control condition.

Primary Outcome

Defined as having at least one HIV viral load and/or CD4 count laboratory test within the six-month period of study enrollment during which the UBI intervention will be implemented at the same period. We also will use medical chart abstraction to confirm self-reported use of HIV care services.

Interventions

  • BEHAVIORAL Universal Basic Income

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-08-03
Est. Completion 2026-12-31
Phase NA
University of Arkansas

318 total trials

What NCT06186128 shows while recruiting

NCT06186128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Universal Basic Income is the first listed.

NCT06186128 reports a single indexed study location in Arkansas.

Frequently Asked Questions

What is clinical trial NCT06186128 about?

NCT06186128 is a clinical study titled "Universal Basic Income and Structural Racism in the US South: HIV Care". Universal Basic Income (UBI) is a promising strategy aimed at recalibrating economic systems that are grounded in structural racism. Black men have long been the target of oppressive and interconnected systems of finance and healthcare access, leading to a disproportionate burden of exposure to infe...

What is the current status of trial NCT06186128?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-08-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06186128 study?

This clinical trial studies the following conditions: HIV, Health Care Utilization.

What interventions are being tested in trial NCT06186128?

The interventions under investigation include: Universal Basic Income (BEHAVIORAL).

Who is sponsoring clinical trial NCT06186128?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06186128 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06186128's enrollment target sits among peer trials

80 175th of 303 higher than 124 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06186128, the US trial registry maintained by the National Library of Medicine. NCT06186128 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.